Author

Abhisekh Sah

Institution: RIMT University

Observed institution: RIMT University

ORCID: 0009-0002-5183-7348

Observed ORCID: 0009-0002-5183-7348

OpenAlex ID: A5137630207

Folate receptor-α targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies

2026 · Bishal Singh, Dilpreet Singh, et al. · International Immunopharmacology · 4

Lymphatic–Targeted Nanoparticle Drug Delivery for Early Cancer Metastasis and Lymphoma: Bypassing Hepatic First–Pass Metabolism

2026 · Bishal Singh, Abhisekh Sah, et al. · Nano LIFE · 1

Ingestible smart capsules: from engineering innovation to GI drug delivery

2026 · Dilpreet Singh, Pallvi Kumari, et al. · Biomedical Microdevices · 1

From Biomimicry to Translational Readiness: Barrier-Centric Design Principles for Intracellular Protein and Genome-Editing RNP Nanodelivery

2026 · Bishal Singh, Abhisekh Sah, et al. · Nano LIFE

Beyond Nanosizing: Mechanism-Guided Design and Rational Selection of Polymeric and Lipid Nanocarriers for Translatable Drug Delivery

2026 · Bishal Singh, Abhisekh Sah, et al. · DARU Journal of Pharmaceutical Sciences

Toward AI-integrated Digital Twin Frameworks for Nanocarrier-Mediated CRISPR Gene Editing: A Perspective

2026 · Abhisekh Sah, Bishal Singh, et al. · Nano LIFE

DRT3-mediated protein-directed DNA synthesis: Mechanism, evolutionary context and engineering prospects

2026 · Bishal Singh, Abhisekh Sah, et al. · Gene Reports

Wearable hydrogel-integrated microfluidic platforms for controlled cutaneous and transdermal drug delivery: engineering design, stimuli-responsive release, and computational modeling

2026 · Abhisekh Sah, Bishal Singh, et al. · Biomedical Microdevices

Works count: 8

Citation count: 6

H-index: 1

I10-index: